Seth Berk

Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.

M. Ratain, T. Zimmerman, R. Larson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

post-transcriptional level Farnesyltransferase inhibitors inhibit T cell cytokine production at the

T. Gajewski, R. Marks, A. Ho, 2010 .

Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level.

T. Gajewski, R. Marks, A. Ho, 2007, Blood.